Chimerix, Inc.
News
Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire DURHAM, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of...\n more…
Chimerix (NASDAQ:CMRX) Shares Cross Below 200 Day Moving Average of $0.97
Ticker Report Chimerix, Inc. (NASDAQ:CMRX - Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.97 and traded as low as $0.93...\n more…
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire DURHAM, N.C., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on August 20, 2024, the Compensation Committee of Chimerix's Board of Directors granted an inducement...\n more…
Assenagon Asset Management S.A. Has $355,000 Stake in Chimerix, Inc. (NASDAQ:CMRX)
Ticker Report Assenagon Asset Management S.A. lessened its stake in shares of Chimerix, Inc. (NASDAQ:CMRX - Free Report) by 10.9% during the second quarter, according to its most recent filing with the Securities...\n more…
Chimerix (NASDAQ:CMRX) Upgraded to "Hold" at StockNews.com
Ticker Report Chimerix (NASDAQ:CMRX - Get Free Report) was upgraded by research analysts at StockNews.com from a "sell" rating to a "hold" rating in a research note issued on Wednesday. Several other research...\n more…